Panel Discussion: Shaping Investment in Induced Proximity: Insights to Accelerate Development & Secure Funding
- Exploring the data, targets, and indications investors are prioritizing to support next-generation induced proximity therapeutics
- Discussing funding strategies for early-stage companies, including milestones needed to secure investment and attract pharmaceutical partnerships
- Evaluating how scientific innovation and emerging modalities influence investor confidence and the types of assets and platforms likely to attract investor interest